Literature DB >> 9817700

Bronchoalveolar lavage alterations in pulmonary embolism.

G Nakos1, E I Kitsiouli, M E Lekka.   

Abstract

The objective of this study was to determine quantitative and qualitative surfactant alterations, proteins, and platelet activating factor (PAF) in bronchoalveolar lavage (BAL) fluid from patients with pulmonary thromboembolism (PTE) with respect to ventilated patients without PTE. Patients with PTE underwent BAL at the most affected lung area on the first and tenth days of PTE diagnosis. Total proteins and albumin, total lipids, individual phospholipid classes, PAF and PAF-acetylhydrolase (PAF-AcH) activity were determined in BAL fluid. Total proteins and albumin were found to be increased in both successive samples of patients with PTE when compared with the control group (p < 0.001 and p < 0.05, respectively). Total phospholipids, though, were elevated on the first day, but they decreased on the tenth day, in comparison with the control groups (p < 0.05). Alterations in the percentage of individual phospholipid classes were observed in both successive samples of BAL fluid when compared with those in the control subjects. PAF and PAF-AcH were detected in high levels on the first day (p < 0.001), which were reduced on the tenth day (p < 0.05). An inverse correlation between PAF levels and PaO2/FIO2 ratio was observed. Finally, the percentage of macrophages decreased and the percentage of neutrophils increased during the course of PTE. In conclusion, pulmonary embolism is associated with alterations in lung surfactant and inflammation in lung tissue, expressed by an increase in PAF and in neutrophils.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817700     DOI: 10.1164/ajrccm.158.5.9802036

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  6 in total

Review 1.  The value of electrocardiographic abnormalities in the prognosis of pulmonary embolism: a consensus paper.

Authors:  Geneviève C Digby; Piotr Kukla; Zhong-Qun Zhan; Carlos A Pastore; Ryszard Piotrowicz; Edgardo Schapachnik; Wojciech Zareba; Antonio Bayés de Luna; Piotr Pruszczyk; Adrian M Baranchuk
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-05       Impact factor: 1.468

2.  Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism.

Authors:  Jeffrey A Kline; Nury M Steuerwald; John A Watts; Mark Courtney; Herbert L Bonkovsky
Journal:  Thromb Res       Date:  2015-08-28       Impact factor: 3.944

Review 3.  Lung surfactant alterations in pulmonary thromboembolism.

Authors:  A Calkovska; D Mokra; V Calkovsky
Journal:  Eur J Med Res       Date:  2009-12-07       Impact factor: 2.175

Review 4.  Mechanisms of hypoxemia.

Authors:  Malay Sarkar; N Niranjan; P K Banyal
Journal:  Lung India       Date:  2017 Jan-Feb

5.  Modulation of soluble guanylate cyclase ameliorates pulmonary hypertension in a rat model of chronic thromboembolic pulmonary hypertension by stimulating angiogenesis.

Authors:  John Zagorski; Evandro Neto-Neves; Nathan J Alves; Amanda J Fisher; Jeffrey A Kline
Journal:  Physiol Rep       Date:  2022-01

6.  Plasma metabolomic profile in chronic thromboembolic pulmonary hypertension.

Authors:  Gustavo A Heresi; Jacob T Mey; John R Bartholomew; Ihab S Haddadin; Adriano R Tonelli; Raed A Dweik; John P Kirwan; Satish C Kalhan
Journal:  Pulm Circ       Date:  2020-02-04       Impact factor: 3.017

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.